Visualitza per autor "Martínez Martín, Sandra"
Ara mostrant els elements 1-5 d 5
-
MYC inhibitors in multiple myeloma
Martínez Martín, Sandra; Soucek, Laura (OAE Publishing, 2021-08-13) -
MYC targeting by OMO-103 in solid tumors: a phase 1 trial
Moreno, Victor; Martínez Martín, Sandra; Alonso-Casal, Guzman; Arqués, Oriol; GARRALDA, Elena; Beaulieu, Marie-Eve; Casacuberta-Serra, Sílvia; Foradada Felip, Laia; Perez-Lopez, Raquel; Whitfield, Jonathan; Soucek, Laura (Nature Portfolio, 2024-02-06) -
Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue
Martínez Martín, Sandra; Castillo Cano, Virginia; Massó Vallés, Daniel; López-Estévez, Sergio; Thabussot, Hugo; Beaulieu, Marie-Eve; Soucek, Laura; Foradada Felip, Laia; Kaur, Jastrinjan; Serrano del Pozo, Erika (MDPI, 2023-01-29) -
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma
Zacarias Fluck, Mariano F; Massó-Vallés, Daniel; Giuntini, Fabio; González-Larreategui, Íñigo; Kaur, Jastrinjan; Casacuberta-Serra, Sílvia; Jauset González, Antoni; Martínez Martín, Sandra; Martín Fernández, Génesis; Serrano del Pozo, Erika; Foradada Felip, Laia; Grueso Gragera, Judit; Nonell Malezon, Lara; Whitfield, Jonathan; Beaulieu, Marie-Eve; Soucek, Laura (Cold Spring Harbor Laboratory Press, 2023-04-01) -
Targeting MYC-driven lymphoma: lessons learned and future directions
Martínez Martín, Sandra; Beaulieu, Marie-Eve; Soucek, Laura (OAE Publishing, 2023-04-12)